Evidence map›Paper›PMID 35821088›Full record

ArticleCell research2022

Depression compromises antiviral innate immunity via the AVP-AHI1-Tyk2 axis.

Hong-Guang Zhang, Bin Wang, Yong Yang, Xuan Liu, Junjie Wang, Ning Xin, Shifeng Li, Ying Miao, Qiuyu Wu, Tingting Guo and 10 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
10.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. 5-HTJournal of advanced research · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. PMProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors at 1 institution in 1 country.

Hong-Guang Zhang *International Institute of Infection and Immunity, Institutes of Biology and Medical Sciences, Soochow University, Suzhou, Jiangsu, China.
Bin Wang *Institute of Neuroscience, Soochow University, Suzhou, Jiangsu, China.
Yong YangDepartment of Psychiatry, the Affiliated Guangji Hospital of Soochow University, Suzhou, Jiangsu, China.ORCID 0000-0003-2327-2028
Xuan LiuDepartment of Neurology, the First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
Junjie WangInstitute of Neuroscience, Soochow University, Suzhou, Jiangsu, China.
Ning XinInstitute of Neuroscience, Soochow University, Suzhou, Jiangsu, China.
Shifeng LiDepartment of Intensive Care Medicine, the First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
Ying MiaoInternational Institute of Infection and Immunity, Institutes of Biology and Medical Sciences, Soochow University, Suzhou, Jiangsu, China.
Qiuyu WuInternational Institute of Infection and Immunity, Institutes of Biology and Medical Sciences, Soochow University, Suzhou, Jiangsu, China.
Tingting GuoInternational Institute of Infection and Immunity, Institutes of Biology and Medical Sciences, Soochow University, Suzhou, Jiangsu, China.
Yukang YuanInternational Institute of Infection and Immunity, Institutes of Biology and Medical Sciences, Soochow University, Suzhou, Jiangsu, China.
Yibo ZuoInternational Institute of Infection and Immunity, Institutes of Biology and Medical Sciences, Soochow University, Suzhou, Jiangsu, China.
Xiangjie ChenInternational Institute of Infection and Immunity, Institutes of Biology and Medical Sciences, Soochow University, Suzhou, Jiangsu, China.
Tengfei RenInternational Institute of Infection and Immunity, Institutes of Biology and Medical Sciences, Soochow University, Suzhou, Jiangsu, China.
Chunsheng DongInternational Institute of Infection and Immunity, Institutes of Biology and Medical Sciences, Soochow University, Suzhou, Jiangsu, China.
Jun WangDepartment of Intensive Care Medicine, the First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
Hang RuanInternational Institute of Infection and Immunity, Institutes of Biology and Medical Sciences, Soochow University, Suzhou, Jiangsu, China.
Miao SunInstitute for Fetology, the First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
Xingshun XuInstitute of Neuroscience, Soochow University, Suzhou, Jiangsu, China. xingshunxu@suda.edu.cn.ORCID 0000-0003-0205-6342
Hui ZhengInternational Institute of Infection and Immunity, Institutes of Biology and Medical Sciences, Soochow University, Suzhou, Jiangsu, China. huizheng@suda.edu.cn.ORCID 0000-0002-4325-4946
Soochow University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Depression is a serious public-health issue. Recent reports have suggested higher susceptibility to viral infections in depressive patients. However, how depression affects antiviral innate immune signaling remains unknown. Here, we revealed a reduction in expression of Abelson helper integration site 1 (AHI1) in the peripheral blood mononuclear cells (PBMCs) and macrophages from the patients with major depressive disorder (MDD), which leads to attenuated antiviral immune response. We found that depression-related arginine vasopressin (AVP) induces reduction of AHI1 in macrophages. Further studies demonstrated that AHI1 is a critical stabilizer of basal type-I-interferon (IFN-I) signaling. Mechanistically, AHI1 recruits OTUD1 to deubiquitinate and stabilize Tyk2, while AHI1 reduction downregulates Tyk2 and IFN-I signaling activity in macrophages from both MDD patients and depression model mice. Interestingly, we identified a clinical analgesic meptazinol that effectively stimulates AHI1 expression, thus enhancing IFN-I antiviral defense in depression model mice. Our study promotes the understanding of the signaling mechanisms of depression-mediated antiviral immune dysfunction, and reveals meptazinol as an enhancer of antiviral innate immunity in depressive patients.

Indexed as

Major Depressive DisorderMeptazinolAdaptor Proteins, Vesicular TransportAnimalsArginine VasopressinDepressionImmunity, InnateInterferonsLeukocytes, MononuclearMiceAdaptor Proteins, Vesicular TransportAhi1 protein, mouseArginine VasopressinInterferonsMeptazinol

Identifiers

PMID35821088
PMCPMC9274186
OpenAlexW4285092934

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.